You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 4, October 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cataracts in Rheumatoid Arthritis Patients Treated with Corticosteroids

Description and Differential Diagnosis

R. B. OGLESBY, M.D.; R. L. BLACK, M.D.; L. von SALLMANN, M.D.; J. J. BUNIM, M.D.

Arch Ophthalmol. 1961;66(4):519-523.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A previous report by us1 has detailed the occurrence of posterior subcapsular cataracts (PSC) in 5 of 22 (23%) rheumatoid arthritis patients treated with 10-16 mg. of prednisone or its equivalent daily for one year or more and in 12 of 16 (75%) treated with 16 mg. or more. The age of the patients and the duration and severity of rheumatoid arthritis showed no significant correlation with the development of cataracts, and since no cataract of this type was seen in 19 rheumatoid arthritis patients who were not treated with corticosteroids, it was suggested that corticosteroids were the chief etiological factor. It is the purpose of this paper to delineate and discuss the cataracts of the above 17 patients from an ophthalmologic orientation.

Material and Methods

The population was composed of 5 females and 12 males, ranging in age from 34 to 61 years. . . . [Full Text PDF of this Article]


Author Affiliations

Bethesda, Md.

From the Ophthalmology Branch, National Institute of Neurological Diseases and Blindness and the Arthritis and Rheumatism Branch, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, U.S. Public Health Service, U.S. Department of Health, Education, and Welfare.


Footnotes

Submitted for publication July, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.